RNA-binding motifs of hnRNP K are critical for induction of antibody diversification by activation-induced cytidine deaminase.


Journal

Proceedings of the National Academy of Sciences of the United States of America
ISSN: 1091-6490
Titre abrégé: Proc Natl Acad Sci U S A
Pays: United States
ID NLM: 7505876

Informations de publication

Date de publication:
26 05 2020
Historique:
pubmed: 10 5 2020
medline: 19 8 2020
entrez: 10 5 2020
Statut: ppublish

Résumé

Activation-induced cytidine deaminase (AID) is the key enzyme for class switch recombination (CSR) and somatic hypermutation (SHM) to generate antibody memory. Previously, heterogeneous nuclear ribonucleoprotein K (hnRNP K) was shown to be required for AID-dependent DNA breaks. Here, we defined the function of major RNA-binding motifs of hnRNP K, GXXGs and RGGs in the K-homology (KH) and the K-protein-interaction (KI) domains, respectively. Mutation of GXXG, RGG, or both impaired CSR, SHM, and

Identifiants

pubmed: 32385154
pii: 1921115117
doi: 10.1073/pnas.1921115117
pmc: PMC7261133
doi:

Substances chimiques

Antibodies 0
Heterogeneous-Nuclear Ribonucleoprotein K 0
Immunoglobulin Heavy Chains 0
AICDA (activation-induced cytidine deaminase) EC 3.5.4.-
Cytidine Deaminase EC 3.5.4.5

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

11624-11635

Déclaration de conflit d'intérêts

The authors declare no competing interest.

Références

Oncogene. 2001 Sep 10;20(40):5580-94
pubmed: 11607811
J Gen Virol. 2008 Oct;89(Pt 10):2540-2549
pubmed: 18796723
Cells. 2019 Jan 17;8(1):
pubmed: 30658384
Mol Cell Biol. 1992 Jan;12(1):164-71
pubmed: 1729596
RNA. 2002 Mar;8(3):265-78
pubmed: 12003487
Immunity. 1996 Jan;4(1):57-65
pubmed: 8574852
J Mol Biol. 2006 Aug 18;361(3):470-81
pubmed: 16854432
J Immunol. 2012 Jun 1;188(11):5528-37
pubmed: 22547703
eNeuro. 2017 Dec 12;4(6):
pubmed: 29255796
Blood. 2006 Mar 15;107(6):2507-16
pubmed: 16293596
Proc Natl Acad Sci U S A. 2016 Mar 15;113(11):E1545-54
pubmed: 26929374
EMBO J. 2002 Jul 1;21(13):3476-85
pubmed: 12093748
EMBO J. 2012 Oct 17;31(20):4020-34
pubmed: 22960638
Nat Struct Mol Biol. 2011 Jun 05;18(7):796-804
pubmed: 21642970
Nat Immunol. 2003 Sep;4(9):843-8
pubmed: 12910268
Genes Dev. 1988 Feb;2(2):215-27
pubmed: 3129338
Cell. 2015 May 7;161(4):762-73
pubmed: 25957684
Trends Biochem Sci. 2003 Jun;28(6):305-12
pubmed: 12826402
J Neurosci. 2014 Jul 2;34(27):9088-95
pubmed: 24990929
Eur J Hum Genet. 2012 Apr;20(4):381-8
pubmed: 22126750
Bioessays. 2004 Jun;26(6):629-38
pubmed: 15170860
Stem Cell Reports. 2018 Sep 11;11(3):741-755
pubmed: 30174313
Cell. 2010 Aug 6;142(3):409-19
pubmed: 20673990
Carcinogenesis. 2017 Mar 1;38(3):321-328
pubmed: 28426877
Proc Natl Acad Sci U S A. 2013 Feb 5;110(6):2246-51
pubmed: 23341589
Nucleic Acids Res. 2012 Sep;40(16):8059-71
pubmed: 22684629
Proc Natl Acad Sci U S A. 2008 Oct 14;105(41):15866-71
pubmed: 18832469
J Biol Chem. 2006 Apr 21;281(16):11115-25
pubmed: 16492668
EMBO J. 1993 Sep;12(9):3529-37
pubmed: 8253079
Nucleic Acids Res. 2012 Aug;40(14):6873-86
pubmed: 22547390
Clin Genet. 2018 Feb;93(2):401-407
pubmed: 28374925
Science. 1993 Feb 12;259(5097):984-7
pubmed: 8438159
Cell Cycle. 2016 Jun 17;15(12):1552-7
pubmed: 27049467
Cell Signal. 2014 Jul;26(7):1379-84
pubmed: 24642125
Genes Dev. 2016 Jan 15;30(2):149-63
pubmed: 26744420
EMBO J. 1997 Jun 16;16(12):3587-98
pubmed: 9218800
Mol Cell. 2018 Nov 15;72(4):636-649.e8
pubmed: 30293785
J Mol Biol. 2018 Nov 2;430(23):4650-4665
pubmed: 29913160
Cell. 2000 Sep 1;102(5):553-63
pubmed: 11007474
J Exp Med. 2017 Jan;214(1):49-58
pubmed: 27998928
Proc Natl Acad Sci U S A. 2020 May 26;117(21):11624-11635
pubmed: 32385154
Nat Immunol. 2004 Jul;5(7):707-12
pubmed: 15195091
J Biol Chem. 1996 Feb 16;271(7):3420-7
pubmed: 8631943
Proc Natl Acad Sci U S A. 2004 Feb 17;101(7):1975-80
pubmed: 14769937
Proc Natl Acad Sci U S A. 2015 May 5;112(18):5791-6
pubmed: 25902538
Cancer Cell. 2015 Oct 12;28(4):486-499
pubmed: 26412324
Proc Natl Acad Sci U S A. 2011 Nov 29;108(48):19305-10
pubmed: 22080610
Clin Genet. 2017 Nov;92(5):554-555
pubmed: 28771707
J Natl Cancer Inst. 2020 Jan 1;112(1):95-106
pubmed: 31077320
Mol Cell Biol. 1988 May;8(5):2237-41
pubmed: 3386636
J Biol Chem. 2005 Apr 1;280(13):12690-9
pubmed: 15671036
Cell. 1994 Apr 8;77(1):33-9
pubmed: 8156595
Proc Natl Acad Sci U S A. 2014 Dec 2;111(48):17242-7
pubmed: 25404348
Cell Rep. 2016 Sep 6;16(10):2554-2564
pubmed: 27568568
Nature. 2006 Mar 2;440(7080):105-9
pubmed: 16400328
Proc Natl Acad Sci U S A. 2009 Dec 29;106(52):22375-80
pubmed: 20018730
RNA. 2014 Jun;20(6):899-911
pubmed: 24751651
Structure. 2005 Jul;13(7):1055-67
pubmed: 16004877
Nature. 2018 Mar 1;555(7694):107-111
pubmed: 29466324
Eur J Hum Genet. 2018 Sep;26(9):1272-1281
pubmed: 29904177
PLoS One. 2012;7(8):e42106
pubmed: 22879910
Biochem Biophys Res Commun. 2011 Jan 21;404(3):865-9
pubmed: 21184736
Cell. 2005 Dec 16;123(6):1065-78
pubmed: 16360036
Circ Res. 2003 Mar 7;92(4):419-27
pubmed: 12600897
Am J Med Genet A. 2005 Jun 15;135(3):278-81
pubmed: 15887282

Auteurs

Ziwei Yin (Z)

Department of Immunology and Genomic Medicine, Graduate School of Medicine, Kyoto University, 606-8501 Kyoto, Japan.

Maki Kobayashi (M)

Department of Immunology and Genomic Medicine, Graduate School of Medicine, Kyoto University, 606-8501 Kyoto, Japan.

Wenjun Hu (W)

Department of Immunology and Genomic Medicine, Graduate School of Medicine, Kyoto University, 606-8501 Kyoto, Japan.

Koichi Higashi (K)

Center for Information Biology, National Institute of Genetics, Mishima, 411-8540 Shizuoka, Japan.

Nasim A Begum (NA)

Department of Immunology and Genomic Medicine, Graduate School of Medicine, Kyoto University, 606-8501 Kyoto, Japan.

Ken Kurokawa (K)

Center for Information Biology, National Institute of Genetics, Mishima, 411-8540 Shizuoka, Japan.

Tasuku Honjo (T)

Department of Immunology and Genomic Medicine, Graduate School of Medicine, Kyoto University, 606-8501 Kyoto, Japan; honjo@mfour.med.kyoto-u.ac.jp.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH